New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 22, 2012
09:46 EDTTXRH, FIRE, CHS, MDCO, CYH, AUBN, WIRE, GRMN, CLHGappers report: Bullish gaps
This is a list of stocks making unusual moves on the open versus the prior day close. Gapping stocks often have excessive movements during the day and in the days thereafter. We use 5% for filter criteria and scanned for stocks that traded above $10 the prior day. GAPPING UP: WIRE 5.13%, CLH 5.26%, AUBN 5.57%, MDCO 8.11%, TXRH 9.26%, GRMN 9.71%, CYH 11.67%, CHS 13.35%, FIRE 17.09%.
News For AUBN;CHS;CLH;CYH;FIRE;GRMN;MDCO;TXRH;WIRE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
February 19, 2015
09:59 EDTGRMNOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Altisource Residential (RESI) upgraded to Neutral from Sell at Compass Point... Angie's List (ANGI) upgraded to Overweight from Equal-Weight at First Analysis... Barrick Gold (ABX) upgraded to Buy from Hold at TD Securities... British Land (BTLCY) upgraded to Buy from Hold at Societe Generale... Coach (COH) upgraded to Buy from Hold at Topeka... Fiat Chrysler (FCAU) upgraded to Outperform from Neutral at Exane BNP Paribas... Garmin (GRMN) upgraded at BofA/Merrill... Hologic (HOLX) upgraded to Buy from Hold at Canaccord... Iberdrola (IBDRY) upgraded to Neutral from Underweight at HSBC... KPN (KKPNY) upgraded to Neutral from Underperform at Exane BNP Paribas... Monster Worldwide (MWW) upgraded at Evercore ISI... Pharmacyclics (PCYC) upgraded to Buy from Neutral at Nomura... RPC, Inc. (RES) upgraded to Equal Weight from Underweight at Morgan Stanley... Sanofi (SNY) upgraded to Buy from Neutral at BofA/Merrill... Sasol (SSL) upgraded to Neutral from Underweight at HSBC... Tractor Supply (TSCO) upgraded at Oppenheimer... Valero (VLO) upgraded to Buy from Hold at Deutsche Bank... Weingarten Realty (WRI) upgraded to Neutral from Sell at UBS... Werner (WERN) upgraded on improving freight fundamentals at RBC Capital... diaDexus (DDXS) upgraded to Buy from Neutral at Ladenburg,
09:12 EDTGRMNOn The Fly: Pre-market Movers
Subscribe for More Information
07:18 EDTGRMNGarmin upgraded at BofA/Merrill
As previously reported, BofA/Merrill upgraded Garmin to Buy from Neutral. The firm upgraded shares citing the pullback post Q4 results. The analyst believes weakness is overdone and expects Garmin to be able to protect its market share in the activity tracking products priced at $200 and below and to continue to leverage its vertically integrated business model to respond to changing market dynamics. Price target is $60.
06:33 EDTGRMNGarmin upgraded to Buy from Neutral at BofA/Merrill
Subscribe for More Information
February 18, 2015
16:46 EDTGRMNOn The Fly: Closing Wrap
Subscribe for More Information
10:59 EDTGRMNGarmin continues to look for opportunities for tuck-in acquisitions
10:43 EDTGRMNGarmin sees FY15 Automotive/Mobile revenue down about 15%
Subscribe for More Information
09:10 EDTGRMNOn The Fly: Pre-market Movers
Subscribe for More Information
08:54 EDTMDCOThe Medicines Co. anticipates potential partnership talks
Subscribe for More Information
08:52 EDTMDCOThe Medicines Co. anticipates four U.S. FDA approvals in 2015
08:41 EDTMDCOThe Medicines Co. says not giving financial guidance due to Hospira suit
Subscribe for More Information
07:04 EDTGRMNGarmin sees FY15 EPS about $3.10, consensus $3.24
Subscribe for More Information
07:03 EDTGRMNGarmin board authorizes repurchase of up to $300M of common stock
Subscribe for More Information
07:02 EDTGRMNGarmin board intends to recommend cash dividend of $2.04 per share
The board of directors intends to recommend to the shareholders for approval at the annual meeting to be held on June 5 a cash dividend in the amount of $2.04 per share, payable in four equal installments on dates to be determined by the Board.
07:01 EDTMDCOThe Medicines Co. reports Q4 adjusted EPS 20c, consensus (82c)
Subscribe for More Information
07:01 EDTGRMNGarmin reports Q4 adjusted EPS 77c, consensus 78c
Reports Q4 revenue $803.31M, consensus $789.94M.
February 17, 2015
15:40 EDTGRMNGarmin technical comments ahead of results
Ahead of earnings the shares are moving higher, trading above the midpoint of the 1-year range. If the news meets or exceeds bullish expectations, next resistance levels are at $58.13, $60.19, and the 52-week high at $62.05. If the news fails to meet expectations, the following support levels could become downside objectives: $54.66, $52.89, and $50.08. A breakdown below $50 would snap the longer-term uptrend.
15:32 EDTGRMNNotable companies reporting before tomorrow's open
Subscribe for More Information
14:21 EDTGRMNGarmin November volatility elevated into Q3 and outlook
Garmin March put option implied volatility is at 83, March is at 31, April is at 28; compared to its 26-week average of 27 according to Track Data, suggesting large price movement into the expected release of Q4 results on February 18.
06:47 EDTCYHJudge halts illegal immigrant amnesty plan, NY Times says
A federal judge ordered the Obama administration to stop implementing its plan to prevent up to 5M illegal immigrants from being deported, according to The New York Times. The judge, who ruled that the government had failed to adhere to certain administrative rules in carrying out the president's executive actions on immigration, ordered the programs halted until he makes a final decision on the case, the newspaper explained. A number of analysts have said that the amnesty plan will hurt hospitals, since illegal immigrants who are granted legal status by the orders will not be able to obtain health insurance but will become more likely to seek treatment from hospitals. Publicly traded companies in the space include Community Health (CYH), HCA Holdings (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS).Reference Link
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use